Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Common Stock, $0.01 Par Value
-
Shares outstanding
-
22.7M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
17.3M
-
Shares change
-
+361K
-
Total reported value, excl. options
-
$562M
-
Value change
-
+$13.7M
-
Number of buys
-
62
-
Number of sells
-
-62
-
Price
-
$32.53
Significant Holders of LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) as of Q3 2020
155 filings reported holding LMAT - LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value as of Q3 2020.
LEMAITRE VASCULAR INC - Common Stock, $0.01 Par Value (LMAT) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17.3M shares
of 22.7M outstanding shares and own 76.24% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2.76M shares), Conestoga Capital Advisors, LLC (1.88M shares), VANGUARD GROUP INC (1.1M shares), GENEVA CAPITAL MANAGEMENT LLC (915K shares), Copeland Capital Management, LLC (888K shares), DIMENSIONAL FUND ADVISORS LP (840K shares), Ranger Investment Management, L.P. (747K shares), STATE STREET CORP (663K shares), PRINCIPAL FINANCIAL GROUP INC (501K shares), and Summit Creek Advisors LLC (472K shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.